Literature DB >> 21246338

[Overweight and obesity in childhood and adolescence. Evaluation of inpatient and outpatient care in Germany: the EvAKuJ study].

U Hoffmeister1, M Bullinger, A van Egmond-Fröhlich, C Goldapp, R Mann, U Ravens-Sieberer, T Reinehr, J Westenhöfer, N Wille, R W Holl.   

Abstract

Numerous forms of therapy exist for the increasing number of obese children and adolescents in Germany, but these are heterogeneous and have not been evaluated. Access to health care, long- and short-term treatment outcome, as well as factors determining success of therapy were examined for the first time using standardized instruments to measure somatic and psychosocial variables. A total of 1,916 children aged 8-16 years from 48 (5 rehabilitation, 43 outpatient) institutions were examined. Data were collected for height, weight, blood pressure, and lipid status before treatment started (t0), at the end of treatment (t1), and 1 year after completion of treatment (t2). Furthermore, psychosocial variables were documented using questionnaires for parents and children. The mean BMI-SDS (body mass index standard deviation score) reduction at t1 was -0.27 and 1 year later at t2 was -0.23 (per protocol analysis; intention to treat: t1=-0.24; t2=-0.06). Psychological health and quality of life, which were markedly impaired at the beginning, improved. However, physical activity, media consumption, and nutrition remained basically unchanged. A reduction in weight is associated with an improvement in cardiovascular risk profiles, and long-term behavior changes are possible. However, the institutions differed considerably in the percentage of follow-up examinations and in the weight reduction accomplished.

Entities:  

Mesh:

Year:  2011        PMID: 21246338     DOI: 10.1007/s00103-010-1193-x

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  7 in total

1.  Media Use and Physical Activity Behaviour of Adolescent Participants in Obesity Therapy: Impact Analysis of Selected Socio-Demographic Factors.

Authors:  Hagen Wulff; Petra Wagner
Journal:  Obes Facts       Date:  2018-08-01       Impact factor: 3.942

2.  Changing Characteristics of Obese Children and Adolescents Entering Pediatric Lifestyle Intervention Programs in Germany over the Last 11 Years: An Adiposity Patients Registry Multicenter Analysis of 65,453 Children and Adolescents.

Authors:  Barbara Bohn; Susanna Wiegand; Wieland Kiess; Thomas Reinehr; Rainer Stachow; Johannes Oepen; Helmut Langhof; Thomas Hermann; Kurt Widhalm; Martin Wabitsch; Ines Gellhaus; Reinhard Holl
Journal:  Obes Facts       Date:  2017-10-31       Impact factor: 3.942

3.  Association of symptoms of attention-deficit/hyperactivity disorder with physical activity, media time, and food intake in children and adolescents.

Authors:  Andreas W A van Egmond-Fröhlich; Daniel Weghuber; Martina de Zwaan
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

4.  Emotion regulation strategies predict weight loss during an inpatient obesity treatment for adolescents.

Authors:  Tilman Reinelt; Franz Petermann; Florian Bauer; Carl-Peter Bauer
Journal:  Obes Sci Pract       Date:  2020-02-12

5.  Does an Age-Specific Treatment Program Augment the Efficacy of a Cognitive-Behavioral Weight Loss Program in Adolescence and Young Adulthood? Results from a Controlled Study.

Authors:  Petra Warschburger; Jana Zitzmann
Journal:  Nutrients       Date:  2019-09-02       Impact factor: 5.717

6.  Three- and five-year follow-up of a combined inpatient-outpatient treatment of obese children and adolescents.

Authors:  Sibylle Adam; Joachim Westenhoefer; Birgit Rudolphi; Hanna-Kathrin Kraaibeek
Journal:  Int J Pediatr       Date:  2013-04-18

7.  SRT-Joy - computer-assisted self-regulation training for obese children and adolescents: study protocol for a randomized controlled trial.

Authors:  Petra Warschburger
Journal:  Trials       Date:  2015-12-10       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.